As of 2026-04-03, TScan Therapeutics Inc. (TCRX) trades at a current price of $1.01, marking a 1.94% decline in its most recent trading session. This analysis focuses on key technical levels, prevailing market context, and potential short-term scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company at the time of publication. TCRX, which operates in the engineered T-cell receptor therapy space, has seen muted price action in recent weeks, trading wi
TCRX Stock Analysis: TScan Therapeutics Inc. Biotech at $1 Level Following Small Daily Dip
TCRX - Stock Analysis
4248 Comments
1889 Likes
1
Duvid
Active Contributor
2 hours ago
Iβm taking mental screenshots. πΈ
π 61
Reply
2
Shaeleigh
Daily Reader
5 hours ago
This came just a little too late.
π 211
Reply
3
Haileyjo
Community Member
1 day ago
I read this and now I feel watched.
π 78
Reply
4
Onyinyechukwu
Power User
1 day ago
I wish someone had sent this to me sooner.
π 182
Reply
5
Lyllianna
Legendary User
2 days ago
I read this and now I feel responsible.
π 77
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.